← Leaderboards
Alexander Marson
J. David Gladstone Institutes
$20,805,878
Attributed
$21,922,114
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2016–25$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,180,369 · 17
By mechanism
P01$16,676,510 · 8
U54$3,983,781 · 2
DP3$3,701,002 · 1
R01$2,903,723 · 2
DP2$2,377,500 · 1
U19$1,824,162 · 1
Top collaborators
- Jennifer Maxwell Puck8 shared
- Kole T Roybal3 shared
Most similar at J. David Gladstone Institutes
Same institution · by research overlap
- Melanie Maria Ott$58,597,956
- Ma Somsouk$4,673,950
- Kole T Roybal$7,404,890
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteGeneticCellsGenesClustered Regularly Interspaced Short Palindromic RepeatsGenomicsGenome EditingProgramsVariantMapsMolecularHuman GeneticsComplexGenetic VariantMutationDiagnosisImmuneCrispr/Cas TechnologyGenomeInsightIn VitroKnock-OutTechnologyCollaborations
Grant awards (50)
Project 3$1,208,757
U54 · FY2025 · AI · contact PI
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy$749,187
R01 · FY2025 · CA · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$2,181,037
P01 · FY2024 · AI · contact PI
Project 3$802,661
U54 · FY2024 · AI · contact PI
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy$711,787
R01 · FY2024 · CA · contact PI
Project 3: CRISPR Genome Editing to Understand and Correct STAT3 GOF Immune Dysregulation$471,566
P01 · FY2024 · AI · contact PI
Editing to Create and Correct Gene Variants$419,542
P01 · FY2024 · AI · contact PI
Administrative Core$237,470
P01 · FY2024 · AI · contact PI
Core B: Human Genetics and Genomics Core$175,208
P01 · FY2024 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$2,217,974
P01 · FY2023 · AI · contact PI
Project 3$983,033
U54 · FY2023 · AI · contact PI
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy$771,499
R01 · FY2023 · CA · contact PI
Project 3: CRISPR Genome Editing to Understand and Correct STAT3 GOF Immune Dysregulation$471,566
P01 · FY2023 · AI · contact PI
Editing to Create and Correct Gene Variants$445,243
P01 · FY2023 · AI · contact PI
Core B: Human Genetics and Genomics Core$392,955
P01 · FY2023 · AI · contact PI
Administrative Core$162,285
P01 · FY2023 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$87,059
P01 · FY2023 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$2,217,974
P01 · FY2022 · AI · contact PI
Project 3$989,330
U54 · FY2022 · AI · contact PI
Project 3: CRISPR Genome Editing to Understand and Correct STAT3 GOF Immune Dysregulation$472,500
P01 · FY2022 · AI · contact PI
Editing to Create and Correct Gene Variants$445,449
P01 · FY2022 · AI · contact PI
Core B: Human Genetics and Genomics Core$173,910
P01 · FY2022 · AI · contact PI
Administrative Core$162,359
P01 · FY2022 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$105,480
P01 · FY2022 · AI · contact PI
Administrative Core$105,480
P01 · FY2022 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$12,783
P01 · FY2022 · AI · contact PI
Administrative Core$12,783
P01 · FY2022 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$2,217,974
P01 · FY2021 · AI · contact PI
CORE 2: Technology Core$597,168
U19 · FY2021 · AI · contact PI
Editing to Create and Correct Gene Variants$419,755
P01 · FY2021 · AI · contact PI
CRISPR in Primary Cells to Study HIV-Host Function$339,799
P50 · FY2021 · AI · contact PI
Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants$189,000
R01 · FY2021 · DK · contact PI
Administrative Core$161,080
P01 · FY2021 · AI · contact PI
Inherited T cell defects: Diagnosis, Mechanisms and Treatments$2,217,974
P01 · FY2020 · AI · contact PI
Editing to Create and Correct Gene Variants$612,303
P01 · FY2020 · AI · contact PI
CORE 2: Technology Core$419,748
U19 · FY2020 · AI · contact PI
CRISPR in Primary Cells to Study HIV-Host Function$341,679
P50 · FY2020 · AI · contact PI
Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants$161,500
R01 · FY2020 · DK · contact PI
Administrative Core$76,801
P01 · FY2020 · AI · contact PI
CORE 2: Technology Core$440,831
U19 · FY2019 · AI · contact PI
CRISPR in Primary Cells to Study HIV-Host Function$347,010
P50 · FY2019 · AI · contact PI
Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants$160,666
R01 · FY2019 · DK · contact PI
CORE 2: Technology Core$366,415
U19 · FY2018 · AI · contact PI
CRISPR in Primary Cells to Study HIV-Host Function$342,138
P50 · FY2018 · GM · contact PI
Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants$160,084
R01 · FY2018 · DK · contact PI
CRISPR in Primary Cells to Study HIV-Host Function$343,065
P50 · FY2017 · GM · contact PI
Functional Interrogation of Non-Coding Type 1 Diabetes Risk Variants in Human Immune Cells and Beta Cells$3,282,897
DP3 · FY2016 · DK · contact PI
Functional Testing of Host Genes that control HIV Latency in Primary Immune Cells$2,195,087
DP2 · FY2016 · DA · contact PI
Functional Interrogation of Non-Coding Type 1 Diabetes Risk Variants in Human Immune Cells and Beta Cells$418,105
DP3 · FY2016 · DK · contact PI
Functional Testing of Host Genes that Control HIV Latency in Primary Immune Cells$182,413
DP2 · FY2016 · DA · contact PI